1 Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
来源：JAMA-J AM MED ASSOC( P 0098-7484 E 1538-3598 ) 发表时间: 2020/04
类型：期刊论文 为本人加分：52235.680000
2 Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
来源：SCI CHINA LIFE SCI( P 1674-7305 E 1869-1889 ) 发表时间: 2020/03
类型：期刊论文 为本人加分：37985.760000
3 Clinical Characteristics of Coronavirus Disease 2019 in China
来源：NEW ENGL J MED( P 0028-4793 E 1533-4406 ) 发表时间: 2020/04
类型：期刊论文 为本人加分：26736.600000
4 Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
来源：NAT MED( P 1078-8956 E 1546-170X ) 发表时间: 2020/06
类型：期刊论文 为本人加分：18644.800000
5 A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
来源：SCIENCE( P 0036-8075 E 1095-9203 ) 发表时间: 2020/06
类型：期刊论文 为本人加分：14247.200000
6 Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
来源：EMERG MICROBES INFEC( P E 2222-1751 ) 发表时间: 2020/01
类型：期刊论文 为本人加分：13025.920000
7 COVID-19: Abnormal liver function tests
来源：J HEPATOL( P 0168-8278 E 1600-0641 ) 发表时间: 2020/09
类型：期刊论文 为本人加分：11293.120000
8 COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
来源：ALLERGY( P 0105-4538 E 1398-9995 ) 发表时间: 2020/07
类型：期刊论文 为本人加分：8304.960000
9 First case of COVID-19 complicated with fulminant myocarditis: a case report and insights
来源：INFECTION( P 0300-8126 E 1439-0973 ) 发表时间: 2020/10
类型：期刊论文 为本人加分：8230.400000
10 Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020
来源：EMERG INFECT DIS( P 1080-6040 E 1080-6059 ) 发表时间: 2020/06
类型：期刊论文 为本人加分：7779.520000